| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |